Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

Huh? I would expect data in November. Maybe December because of Thanksgiving.

It's gonna be something like 18% of patients that took Brilacidin developed Severe OM. While 72% of patients that took placebo developed severe OM. No SAEs.

The 18% of severe OM will have a reduced duration by weeks compared to placebo.

Hoping for 15-20% range. That will demand a large partnership. IMO.